337 related articles for article (PubMed ID: 2676316)
21. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
[TBL] [Abstract][Full Text] [Related]
22. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
[TBL] [Abstract][Full Text] [Related]
23. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
24. Management of the patient with ascites.
Bruckstein AH
Postgrad Med; 1987 Oct; 82(5):277-8, 281-3, 286. PubMed ID: 3313339
[TBL] [Abstract][Full Text] [Related]
25. [Role of surgery in the treatment of refractory ascites in cirrhotic patients].
Borie DC; Vaillant JC; Breton S; Hannoun L
Ann Chir; 1999; 53(10):966-72. PubMed ID: 10670142
[TBL] [Abstract][Full Text] [Related]
26. The management of ascites and hyponatremia in cirrhosis.
Ginès P; Cárdenas A
Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
[TBL] [Abstract][Full Text] [Related]
27. Management of ascites in patients with chronic liver disease.
Aiza I; Perez GO; Schiff ER
Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
[No Abstract] [Full Text] [Related]
28. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
[TBL] [Abstract][Full Text] [Related]
29. Strategies in the treatment of ascites.
Schölmerich J
Hepatogastroenterology; 1991 Oct; 38(5):365-70. PubMed ID: 1765352
[TBL] [Abstract][Full Text] [Related]
30. Refractory ascites: definition, pathogenesis and treatment.
Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
[TBL] [Abstract][Full Text] [Related]
31. The pathophysiologic basis for the treatment of cirrhotic ascites.
Wong F; Blendis L
Clin Liver Dis; 2001 Aug; 5(3):819-32. PubMed ID: 11565142
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
Stanley AJ; Bouchier IA; Hayes PC
Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
[TBL] [Abstract][Full Text] [Related]
33. [Modern therapy of ascites in liver cirrhosis].
Brodanová M
Vnitr Lek; 1995 Mar; 41(3):189-92. PubMed ID: 7762178
[TBL] [Abstract][Full Text] [Related]
34. Management of ascites.
Yu AS; Hu KQ
Clin Liver Dis; 2001 May; 5(2):541-68, viii. PubMed ID: 11385975
[TBL] [Abstract][Full Text] [Related]
35. A clinical view of recent advances in ascites.
Kandel G; Diamant NE
J Clin Gastroenterol; 1986 Feb; 8(1):85-99. PubMed ID: 3517134
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
37. Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
Wong F; Gines P; Watson H; Horsmans Y; Angeli P; Gow P; Minini P; Bernardi M
J Hepatol; 2010 Aug; 53(2):283-90. PubMed ID: 20541828
[TBL] [Abstract][Full Text] [Related]
38. [Therapy in hepatic ascites].
Knoblauch M
Praxis (Bern 1994); 1995 May; 84(19):561-3. PubMed ID: 7792465
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and therapy of ascites in liver cirrhosis.
Biecker E
World J Gastroenterol; 2011 Mar; 17(10):1237-48. PubMed ID: 21455322
[TBL] [Abstract][Full Text] [Related]
40. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Arroyo V
Ann Hepatol; 2002; 1(2):72-9. PubMed ID: 15115971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
